Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Bone Biologics Corp. (BBLG) had Normalized Income after Taxes of $-3.11M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-3.11M |
|
-- |
|
-- |
|
$3.23M |
|
$-3.23M |
|
$0.13M |
|
$-3.11M |
|
$-3.11M |
|
$-3.11M |
|
$-3.11M |
|
$-3.11M |
|
|
Normalized Income after Taxes |
$-3.11M |
$-3.23M |
|
$-3.23M |
|
1.17M |
|
1.17M |
|
$-2.65 |
|
$-2.65 |
|
| Balance Sheet Financials | |
$5.80M |
|
-- |
|
-- |
|
$5.80M |
|
$0.42M |
|
-- |
|
-- |
|
$0.42M |
|
$5.38M |
|
$5.38M |
|
$5.38M |
|
1.79M |
|
| Cash Flow Statement Financials | |
$-2.69M |
|
-- |
|
$4.70M |
|
$3.33M |
|
$5.33M |
|
$2.01M |
|
$0.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.69M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-57.81% |
|
-57.81% |
|
-53.64% |
|
-57.81% |
|
$3.00 |
|
$-2.29 |
|
$-2.29 |
|